Cadence Pharmaceuticals Inc., of San Diego, dropped its exclusive option to acquire Redwood City, Calif.-based Incline Therapeutics Inc., leaving the specialty pharma free to be acquired by The Medicines Co., of Parsippany, N.J., for $185 million up front, plus regulatory and commercial milestones.